Breast Screening Frequency Trial Group; United Kingdom Co-ordinating Committee on Cancer Research. The frequency of breast cancer screening: results from the UKCCCR randomised trial. Eur J Cancer. 2002;38(11):1458-1464. doi:10.1016/S0959-8049(01)00397-5PubMedGoogle ScholarCrossref 56. Ar...
Breast cancer articles withinCell Death & Disease Featured Article 16 November 2024|Open Access FATS inhibits the Wnt pathway and induces apoptosis through degradation of MYH9 and enhances sensitivity to paclitaxel in breast cancer Jin-Xuan Song ...
p53 mutation remains the most common genetic change identified in human neoplasia. In breast cancer, p53 mutation is associated with more aggressive disease and worse overall survival. The frequency of mutation in p53 is, however, lower in breast cancer
A clinical pathway in breast cancer surgery: Pathway monitoring and impact. Geburtshilfe Frauenheilkd 2009; 69(7): 617-22. http://cat.inist.fr/?aModele=afficheN&cpsidt=21672222Richter-Ehrenstein C, Schneider A, Kramer M et al. A clinical pathway in breast cancer surgery: pathway ...
1South East Scotland Breast Screening, Edinburgh, UK Breast Cancer Research 25(S1): P6 Aim: We performed a pilot study with wireless localisations using Saviscout reflector at our screening centre. This was done to establish the benefit of localisations at assessments to improve patient pathway....
Genome-wide association studies have identified breast cancer risk variants in over 150 genomic regions, but the mechanisms underlying risk remain largely unknown. These regions were explored by combining association analysis with in silico genomic featu
IGF1R signaling results in activation of downstream effectors of the AKT-pathway and MAPK-pathway that function to control mRNA translation in breast cancer [4], [7]. However, the extent to which AIB1 participates in IGF-I stimulated mRNA translation in breast cancer is not known. The ...
or to be used collectively as a phenotype in the construction of tumor progression pathway. For example, 'CpG island methylator phenotype' (CIMP) is a distinct trait studied extensively in colorectal cancer. In colorectal cancer, a high frequency of Type C (cancer-associated methylation) loci ...
Ingenuity Pathway Analysis MEC: Mammary epithelial cells NOB: Non-overweight/obese OB: Overweight/obese PCA: Principal component analysis References World Health Organization. Breast cancer. https://www.who.int/cancer/prevention/diagnosis-screening/breast-cancer/en/. Accessed 10 Dec 2019. Center...
Circulating tumour DNA (ctDNA) allows tracking of the evolution of human cancers at high resolution, overcoming many limitations of tissue biopsies. However, exploiting ctDNA to determine how a patient’s cancer is evolving in order to aid clinical decis